Mr. Craig Milne reports

INNOVOTECH INC. GRANTS DIRECTOR'S OPTIONS SUBSEQUENT TO THE ANNUAL MEETING

Innovotech Inc. has granted stock options to its directors as annual remuneration and recognition of their continuing contributions and alignment with long-term shareholder value creation.

A total of 350,000 options have been granted to the company's seven directors, with each director receiving 50,000 options. The options are exercisable at a price of 33 cents per share, representing a 10-per-cent premium to the closing price of the company's common shares on the TSX Venture Exchange on July 9, 2025.

About Innovotech Inc.

Innovotech is a diversified Canadian technology company with business operations in a growing portfolio of specialized laboratory services, biotechnology businesses and proprietary intellectual property. Innovotech manages several subsidiary companies. Innovotech Labs Corp. is a contract research organization that owns and provides proprietary devices for anti-microbial testing in multiple applications and commercializes anti-microbial silver solutions. Keystone Labs Inc. is a DEL-accredited lab serving the Canadian pharmaceutical industry and industrial markets. Innovotech owns a 60-per-cent stake in NouLifeSciences Inc., a company holding intellectual property related to anti-oxidant molecules with potential applications in cosmetics and various medical conditions, including neuropathies.

We seek Safe Harbor.